Roivant Sciences Ltd (ROIV)

Apr 21, 2025

Immunovant makes leadership changes - MSN

Apr 21, 2025

Apr 21, 2025

Roivant Tightens Leadership Grip On Immunovant, Narrows Near-Term IMVT-1402 Focus - insights.citeline.com

Apr 21, 2025

Apr 21, 2025

Cantor Fitzgerald maintains overweight on Roivant Sciences stock By Investing.com - Investing.com South Africa

Apr 21, 2025

Apr 21, 2025

Immunovant Announces Next Phase Of Growth With Roivant Including Changes To Its Leadership Team And Additional Indications - marketscreener.com

Apr 21, 2025

Apr 18, 2025

When (ROIV) Moves Investors should Listen - news.stocktradersdaily.com

Apr 18, 2025

Apr 11, 2025

Is Roivant Sciences Ltd. (ROIV) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Yahoo Finance

Apr 11, 2025

Apr 10, 2025

Roivant Sciences Ltd. (ROIV): Among the Best Low Priced Growth Stocks to Invest In - Insider Monkey

Apr 10, 2025

Apr 07, 2025

Immunovant, Roivant slip after trial data for autoimmune disorder therapy - MSN

Apr 07, 2025

Apr 02, 2025

Knott David M Jr Decreases Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Apr 02, 2025

Apr 02, 2025

KLP Kapitalforvaltning AS Invests $918,000 in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Apr 02, 2025

Mar 31, 2025

ROIV stock touches 52-week low at $9.96 amid market fluctuations By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

ROIV stock touches 52-week low at $9.96 amid market fluctuations - Investing.com Australia

Mar 31, 2025

Mar 29, 2025

Is Roivant Sciences (ROIV) the Best Mid Cap Biotech Stock to Buy? - Insider Monkey

Mar 29, 2025

Mar 29, 2025

Loomis Sayles & Co. L P Has $43.43 Million Stock Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Mar 29, 2025

Mar 28, 2025

Insider Selling: Roivant Sciences Ltd. (NASDAQ:ROIV) COO Sells 315,522 Shares of Stock - MarketBeat

Mar 28, 2025

Mar 25, 2025

Is Roivant Sciences Ltd. (NASDAQ:ROIV) One of The Best Stocks to Buy According to Billionaire David Einhorn? - Insider Monkey

Mar 25, 2025

Mar 25, 2025

Roivant Sciences president Eric Venker sells shares worth $8.19 million By Investing.com - Investing.com UK

Mar 25, 2025

Mar 24, 2025

Roivant Sciences president Eric Venker sells shares worth $8.19 million - Investing.com

Mar 24, 2025

Mar 23, 2025

(ROIV) Trading Advice - news.stocktradersdaily.com

Mar 23, 2025

Mar 20, 2025

Roivant Sciences finalizes consulting agreement with former officer - Investing.com India

Mar 20, 2025

Mar 19, 2025

Roivant Phase III Batoclimab Trial Is Positive, But No Filing Planned - insights.citeline.com

Mar 19, 2025

Mar 19, 2025

Roivant Sciences Says Phase 3 MG Study Meets Primary Endpoint -March 19, 2025 at 08:24 am EDT - Marketscreener.com

Mar 19, 2025

Mar 19, 2025

Roivant Sciences Announces Positive Results for Batoclimab Studies - TipRanks

Mar 19, 2025

Mar 18, 2025

Critical Clinical Data Coming: Roivant's Dual Breakthrough Results in MG and CIDP Studies - Stock Titan

Mar 18, 2025

Mar 12, 2025

(ROIV) Trading Signals - Stock Traders Daily

Mar 12, 2025

Mar 12, 2025

Wall Street Analysts Believe Montes Archimedes Acquisition (ROIV) Could Rally 60%: Here's is How to Trade - Nasdaq

Mar 12, 2025

Mar 11, 2025

Roivant at Leerink’s Conference: Strategic Insights and Developments By Investing.com - Investing.com Australia

Mar 11, 2025

Mar 07, 2025

Does Roivant (ROIV) Offer an Attractive Risk Reward Opportunity? - Insider Monkey

Mar 07, 2025

Mar 04, 2025

Genevant and Arbutus initiate patent lawsuit against Moderna - The Pharma Letter

Mar 04, 2025

Mar 04, 2025

10 Cash-Rich Mid Cap Stocks To Buy Now - Insider Monkey

Mar 04, 2025

Mar 03, 2025

Roivant Sciences Ltd. (ROIV): Among the Cash-Rich Mid Cap Stocks to Buy Now - Insider Monkey

Mar 03, 2025

Mar 02, 2025

Roivant Sciences Ltd. (NASDAQ:ROIV) Shares Bought by New York State Common Retirement Fund - Defense World

Mar 02, 2025

Mar 01, 2025

Trend Tracker for (ROIV) - Stock Traders Daily

Mar 01, 2025

Feb 28, 2025

Principal Financial Group Inc. Lowers Holdings in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 28, 2025

Feb 27, 2025

Handelsbanken Fonder AB Trims Position in Roivant Sciences Ltd. (NASDAQ:ROIV) - MarketBeat

Feb 27, 2025

Feb 27, 2025

Net worth of Vivek Ramaswamy: Roviant Sciences founder who is running for Ohio governor - Times of India

Feb 27, 2025

Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62‐103: Roivant announces Resignation and Replacement of Arbutus Board - The Manila Times

Feb 25, 2025

Feb 25, 2025

Early Warning Report Issued Pursuant to National Instrument 62?103: Roivant announces Resignation and Replacement of Arbutus Board - Lelezard

Feb 25, 2025

Feb 25, 2025

Key milestones in Vivek Ramaswamy’s academic journey: From being a Valedictorian to a member of Harvard P - Times of India

Feb 25, 2025

Feb 24, 2025

Roivant Sciences president Eric Venker sells $1.07 million in shares - Investing.com India

Feb 24, 2025

Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer By Investing.com - Investing.com South Africa

Feb 21, 2025

Feb 21, 2025

Roivant Sciences appoints new Principal Accounting Officer - Investing.com

Feb 21, 2025

Feb 21, 2025

Roivant Sciences Appoints New Chief Accounting Officer - TipRanks

Feb 21, 2025